I'm a company
I'm a talent
(SizeLimitingPyMap: {back_to_blog=Back to the blog, by=by, read=Read time :, min=min})
Back to the blog

The Life Sciences sector in France

Julie Leprohon
by Julie Leprohon Read time : 2min
LinkedIn Icon Facebook Icon Twitter Icon

In the current global health crisis, health is in the spotlight. What part does France play in the international Life Science sector? What about innovation and R&D when the whole world is driven by the search for a way out of the current health crisis? 

The Pharmaceutical Industry in France

The Pharmaceutical industry is a sector that includes research, manufacturing and the production of drugs for human and veterinary medicine. In France, the Pharmaceutical Industry accounted for 60 billion in sales in 2019. Ranked fifth in the world market (1,106 billion in sales), France is one of the major players in the healthcare market. The establishment of the largest pharmaceutical companies in France is the main factor. For example, the Sanofi Pasteur site in Marcy l'Etoile is one of the largest vaccine research, development and production sites in the world. 

The Medical Device industry

These are health products used in humans for diagnosis or therapy. These products act according to a so-called "mechanical" mechanism of action, i.e., neither pharmacological, immunological, nor metabolic.

The Medical Devices sector in France recorded a turnover of €30 billion in 2019 compared to €28 billion in 2016. The number of companies operating in the sector increased by 200% over the year 2019, rising to a total of 1,502 companies. The Medical Device sector in France is undoubtedly showing significant momentum. 

The sector is highly diversified and is principally made up of SMEs, which account for 93% and generate almost 90,000 direct jobs in France. Geographically, these SMEs have a greater presence in the Ile-de-France and Auvergne/Rhône-Alpes regions. 

Innovation and R&D

For decades, innovation and research have been making it possible to treat, cure and save time lost through diseases. The current crisis points to a greater need to continue to prevent risks. 
The total R&D budget for the pharmaceutical industry sector is approximately 4.5 billion euros in France, including 47 million euros of public funding. While the latest research revolves around Covid19 issues, other innovations continue to emerge. 
Some of the projects we might mention are the ENS: the digital health portal that will be available from 01/01/2022. According to Jean-François Delfraissy, President of the Scientific Council, at the Health Innovation Forum on 27/04/2021:"The use of Big Data in healthcare, the use of large databases is something that will
revolutionise patient care and, to some extent, research."

There is no doubt that we will be hearing about digital innovations in the coming years. 
For the medical devices sector, it is estimated that nearly 3,750 patents are filed each year. Connected products represent 51% of these projects. 
In France, 40% of Sanofi's workforce is dedicated to R&D, i.e. approximately 5,000 researchers and scientists. Sanofi has decided to invest 6 billion in R&D over the next 3 years. There is no doubt that the Life Science sector in France is innovative and will result in a significant number of recruitments in the sector. 

The world has been spinning in slow motion for over a year, and today, more than, ever the collective mind has become aware of the importance of health. Investment in R&D, which is very evident in our country, is developing a promising and booming job market. For over three years, Biotalis has been helping its partners find Talents from all over the world in the Life Sciences sector. We can help you recruit your future employees. Why don't we get together and talk about it?  

 Panorama DM 2019  

(String: Read more)